Oncoinvent ASA Strategic Asset Allocation Index
Oncoinvent ASA strategic asset allocation index. Oncoinvent ASA (KLDVK) has a Strategic Asset Allocation Index of 53.8% as of September 2025. Strategic assets (PP&E of Nkr155.67 Million plus long-term investments of Nkr-) total Nkr155.67 Million, measured against net assets of Nkr289.32 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check KLDVK tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Oncoinvent ASA (2022–2024)
Strategic asset allocation index of Oncoinvent ASA from 2022 to 2024. This chart shows how Oncoinvent ASA's Strategic Asset Allocation Index has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the index stands at 53.8%, representing strategic assets of Nkr155.67 Million against net assets of Nkr289.32 Million NOK.
Oncoinvent ASA Strategic Asset Allocation Index by Year (2022–2024)
Oncoinvent ASA strategic asset allocation index by year from 2022 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Oncoinvent ASA from 2022 to 2024, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see KLDVK company net worth.
| Year | SAAI | Strategic Assets (NOK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 50.7% | Nkr135.66 Million | Nkr135.66 Million | Nkr- | Nkr267.76 Million | ▲ +9.4 pp |
| 2023 | 41.3% | Nkr117.11 Million | Nkr117.11 Million | Nkr- | Nkr283.70 Million | ▼ -12.5 pp |
| 2022 | 53.8% | Nkr103.24 Million | Nkr103.24 Million | Nkr- | Nkr192.02 Million | — |